Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
about
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Syndecan-1 is a novel molecula ...... ch and EGFR signaling pathways
@en
Syndecan-1 is a novel molecula ...... h and EGFR signaling pathways.
@nl
type
label
Syndecan-1 is a novel molecula ...... ch and EGFR signaling pathways
@en
Syndecan-1 is a novel molecula ...... h and EGFR signaling pathways.
@nl
prefLabel
Syndecan-1 is a novel molecula ...... ch and EGFR signaling pathways
@en
Syndecan-1 is a novel molecula ...... h and EGFR signaling pathways.
@nl
P2093
P2860
P1433
P1476
Syndecan-1 is a novel molecula ...... ch and EGFR signaling pathways
@en
P2093
Burkhard Greve
Eslam A El-Ghonaimy
Hebatallah Hassan
Hossam Taha Mohamed
Mona Mostafa Mohamed
Omnia Samir
Ramy Gadalla
Sherif Abdelaziz Ibrahim
P2860
P2888
P356
10.1186/S12943-017-0621-Z
P577
2017-03-07T00:00:00Z
P6179
1084251307